MYND Life Sciences MYNDF Stock
MYND Life Sciences Price Chart
MYND Life Sciences MYNDF Financial and Trading Overview
| MYND Life Sciences stock price | 0.0081 USD |
| Previous Close | 0.0081 USD |
| Open | 0.05 USD |
| Bid | 0.008 USD x 2500000 |
| Ask | 0.12 USD x 750000 |
| Day's Range | 0.05 - 0.07 USD |
| 52 Week Range | 0.0081 - 0.07 USD |
| Volume | 7.92K USD |
| Avg. Volume | 0 USD |
| Market Cap | 387.32K USD |
| Beta (5Y Monthly) | 0.964 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
MYNDF Valuation Measures
| Enterprise Value | 3.39M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 387319 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 3386822.2 |
| Enterprise Value/EBITDA | -2.638 |
Trading Information
MYND Life Sciences Stock Price History
| Beta (5Y Monthly) | 0.964 |
| 52-Week Change | -72.33% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.07 USD |
| 52 Week Low | 0.0081 USD |
| 50-Day Moving Average | 0.0081 USD |
| 200-Day Moving Average | 0.01 USD |
MYNDF Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 47.82M |
| Float | 33.24M |
| Short Ratio | N/A |
| % Held by Insiders | 59.82% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | October 31, 2023 |
| Most Recent Quarter (mrq) | July 31, 2024 |
| Next Fiscal Year End | October 31, 2024 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -128598000.00000000000000000000000000000000% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -151.45% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 1 USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -331778 USD |
| EBITDA | -1283700 USD |
| Net Income Avi to Common (ttm) | -542565 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 497 USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 3M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.092 |
| Book Value Per Share (mrq) | -0.09176125 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -172775 USD |
| Levered Free Cash Flow (ttm) | -658037 USD |
Profile of MYND Life Sciences
| Country | United States |
| State | BC |
| City | Port Coquitlam |
| Address | Unit 150 |
| ZIP | V3C 2B2 |
| Phone | N/A |
| Website | https://www.myndsciences.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. MYND Life Sciences Inc. is based in Port Coquitlam, Canada.
Q&A For MYND Life Sciences Stock
What is a current MYNDF stock price?
MYND Life Sciences MYNDF stock price today per share is 0.0081 USD.
How to purchase MYND Life Sciences stock?
You can buy MYNDF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for MYND Life Sciences?
The stock symbol or ticker of MYND Life Sciences is MYNDF.
Which industry does the MYND Life Sciences company belong to?
The MYND Life Sciences industry is Biotechnology.
How many shares does MYND Life Sciences have in circulation?
The max supply of MYND Life Sciences shares is 47.82M.
What is MYND Life Sciences Price to Earnings Ratio (PE Ratio)?
MYND Life Sciences PE Ratio is now.
What was MYND Life Sciences earnings per share over the trailing 12 months (TTM)?
MYND Life Sciences EPS is -0.01 USD over the trailing 12 months.
Which sector does the MYND Life Sciences company belong to?
The MYND Life Sciences sector is Healthcare.